Hap Trading, LLC Aurinia Pharmaceuticals Inc. Put Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	SELL	$17.78 - $33.08 $225,806 - $420,116	-12,700 Reduced 46.18%	14,800 $6,000
Q3 2021 Nov 10, 2021	BUY	$10.93 - $23.55 $15,302 - $32,970	1,400 Added 5.36%	27,500 $19,000
Q2 2021 Aug 11, 2021	SELL	$10.0 - $14.52 $1.88 Million - $2.73 Million	-187,700 Reduced 87.79%	26,100 $60,000
Q4 2020 Feb 16, 2021	BUY	$12.94 - $16.05 $126,812 - $157,290	9,800 Added 4.8%	213,800 $546,000
Q3 2020 Nov 13, 2020	SELL	$13.19 - $16.66 $714,898 - $902,972	-54,200 Reduced 20.99%	204,000 $705,000
Q1 2020 May 08, 2020	BUY	$11.34 - $21.46 $2.93 Million - $5.54 Million	258,200 New	258,200 $919,000

209

58.7M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.15B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.